Public comment opposing sales of medical records to fund HIE

Read the full comments and the March 2020 letter from 22 advocates with concerns Today the CT Health Policy Project submitted public comment opposing the Office of Health Strategy’s medical record privacy policy proposals. Specifically advocates oppose selling access to Connecticut residents’ medical records through paid subscriptions. In addition to the harm to individuals, this…

Read More

JAMA highlights CT bill to limit extreme drug price increases

A recent JAMA article highlights bills to reduce drug price increases across states, including Connecticut’s bill. The bills call for clawing back 80% of drug price increases over inflation plus 2% — a healthy profit that many industries would happily welcome. Other states also considering bills include Massachusetts, Maine, Washington, and Hawaii; more are expected…

Read More

CTNJ: OP-ED | Drug Affordability Requires Limits On Price Gouging

Jay Gironimi has cystic fibrosis and he is grateful for the drugs that help him live. But he disagrees with the Epilepsy Foundation’s opinion piece that defends extreme drug price hikes. “While the drugs are saving lives today, the profit margins are slowly tanking the entire US healthcare system.” Read more

Read More

Response: Lobbyist uses seniors and people with disabilities to protect drug company profits

Reading William Smith’s CT Mirror opinion, I was worried that my state had passed draconian laws that were harming the health of seniors and people with disabilities. Thankfully, that isn’t the case. Our anti-discrimination laws are still in place and functioning. . . . True discrimination against seniors and people with disabilities happens every day…

Read More

CTNJ Opinion: Remember Public Health’s Value After COVID Is Gone

The COVID-19 pandemic has focused a bright light on the weakness of the U.S. public health system. Countries with strong public health systems fared much better in controlling the virus’ spread. America used to have a strong public health system. From 1900 to 2000, life expectancy rose by 30 years. Contrary to public opinion, it…

Read More

Governor’s consultant report recommendations for Medicaid savings are baseless

It’s not in the headlines but the biggest source of potential savings, $200 million, proposed by the Governor’s controversial report from Boston Consulting Group (BCG) to save money in state government to  is to go back to failed Medicaid financial risk models. There are two problems with the proposal. First, the financial risk models don’t…

Read More

Opinion: Innovation isn’t helpful if we can’t afford it

In today’s CT Mirror, Jay Gironimi rebuts an opinion supporting the pharmaceutical industry and explains how extreme drug prices are hurting patients. Jay is supporting the Governor’s bill to tax excessive drug price increases years after the companies have recovered their research costs. Jay has Cystic Fibrosis and needs 10-12 medications daily so he can…

Read More

CTNJ Op-Ed – Drug Innovation Argument Cuts Both Ways

In his recent op-ed, John Burkhardt of Pfizer misses important points when he asserts that the governor’s proposed tax on excessive prescription drug price increases will harm innovation and jobs in Connecticut. He ignores that rising drug prices are making health insurance unaffordable. Overpriced drugs inhibit other innovation and job growth across Connecticut’s economy. He…

Read More

Connecticut individual plans are profitable

Download the report here Individual coverage in Connecticut, , has been more profitable than most states. From 2011 through 2018, each month $55 of premiums went to profit in Connecticut, the 15th highest profitability among states and above the US average of $47. Individual plans in Massachusetts and New York were far less profitable, while…

Read More

Cost Cap finds hospital system costs driving healthcare spending, but we knew that

Download the report In a surprise to no one, the first analysis by the Cost Cap project finds that inpatient and outpatient hospital services are a main driver of rising healthcare spending in Connecticut. Hospital and drug costs have been identified in multiple studies as the main drivers of rising health costs in our state.…

Read More